Transcriptional and functional analysis of Bifidobacterium animalis subsp. lactis exposure to tetracycline

Applied and Environmental Microbiology

Volumn 84, Issue 23, 2018, Pages

  Morovic, Wesley ^a   Roos, Paige ^a   Zabel, Bryan ^a   Hidalgo Cantabrana, Claudio ^b   Kiefer, Anthony ^a   Barrangou, Rodolphe ^b  

^a DUPONT COMPANY   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Antibiotic resistance; ATP luminescence; Bifidobacterium animalis subsp. lactis; Droplet digital PCR; Genomics; RNA sequencing; Tetracycline

Indexed keywords

ANTIBIOTICS; BACTERIA; DROPS; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RNA; SAFETY TESTING;

ANTIBIOTIC RESISTANCE; BIFIDOBACTERIUM ANIMALIS; DIGITAL PCR; GENOMICS; RNA SEQUENCING; TETRACYCLINE;

GENES;

ANTIBIOTIC RESISTANCE; BACTERIUM; GENE EXPRESSION; GENETIC ANALYSIS; GENOMICS; INHIBITION; LUMINESCENCE; PATHOGEN; POLLUTION EXPOSURE; POLYMERASE CHAIN REACTION; PROBIOTICS; PROTEIN; TESTING METHOD;

BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS;

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; TETRACYCLINE;

BACTERIAL GENOME; BIFIDOBACTERIUM ANIMALIS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; TETRACYCLINE RESISTANCE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BIFIDOBACTERIUM ANIMALIS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; GENE EXPRESSION REGULATION, BACTERIAL; GENOME, BACTERIAL; TETRACYCLINE; TETRACYCLINE RESISTANCE; TRANSCRIPTION, GENETIC;

EID: 85056643631     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01999-18     Document Type: Article

References (85)

1. Morovic W, Roper JM, Smith AB, Mukerji P, Stahl B, Rae JC, Ouwehand AC. 2017. Safety evaluation of HOWARU® Restore (Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, Bifidobacterium animalis subsp. lactis Bl-04 and B. lactis Bi-07) for antibiotic resistance, genomic risk factors, and acute toxicity. Food Chem Toxicol 110:316-324. https://doi .org/10.1016/j.fct.2017.10.037
2. Morovic W, Hibberd AA, Zabel B, Barrangou R, Stahl B. 2016. Genotyping by PCR and high-throughput sequencing of commercial probiotic products reveals composition biases. Front Microbiol 7:1747. https://doi.org/ 10.3389/fmicb.2016.01747
3. Patro JN, Ramachandran P, Barnaba T, Mammel MK, Lewis JL, Elkins CA. 2016. Culture-independent metagenomic surveillance of commercially available probiotics with high-throughput next-generation sequencing. mSphere 1:e00057-16. https://doi.org/10.1128/mSphere.00057-16
4. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S. 2014. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506-514. https://doi.org/10.1038/ nrgastro.2014.66
5. WHO, FAO. 2002. Guidelines for the evaluation of probiotics in food. Joint FAO/WHO working group report. London, Ontario, Canada. http:// www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf
6. Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. 2018. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: a double-blind, randomized, placebo-controlled, and dose-ranging trial. Gut Microbes 9:236-251. https://doi.org/10.1080/19490976.2017.1412908
7. Ringel-Kulka T, Palsson OS, Maier D, Carroll I, Galanko JA, Leyer G, Ringel Y. 2011. Clinical trial: probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders-a double-blind study. J Clin Gastroenterol 45:518-525. https://doi.org/10.1097/MCG .0b013e31820ca4d6
8. Waller PA, Gopal PK, Leyer GJ, Ouwehand AC, Reifer C, Stewart ME, Miller LE. 2011. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol 46:1057-1064. https://doi.org/10.3109/00365521 .2011.584895
9. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. 2001. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 74:833-839. https://doi.org/ 10.1093/ajcn/74.6.833
10. Hidalgo-Cantabrana C, Nikolic M, López P, Suárez A, Miljkovic M, Kojic M, Margolles A, Golic N, Ruas-Madiedo P. 2014. Exopolysaccharideproducing Bifidobacterium animalis subsp. lactis strains and their polymers elicit different responses on immune cells from blood and gut associated lymphoid tissue. Anaerobe 26:24-30. https://doi.org/10 .1016/j.anaerobe.2014.01.003
11. Stenman LK, Lehtinen MJ, Meland N, Christensen JE, Yeung N, Saarinen MT, Courtney M, Burcelin R, Lähdeaho M-L, Linros J. 2016. Probiotic with or without fiber controls body fat mass, associated with serum zonulin, in overweight and obese adults-randomized controlled trial. EBioMedicine 13:190-200. https://doi.org/10.1016/j.ebiom.2016.10.036
12. Hibberd AA, Lyra A, Ouwehand AC, Rolny P, Lindegren H, Cedgård L, Wettergren Y. 2017. Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention. BMJ Open Gastroenterol 4:e000145. https://doi.org/10.1136/bmjgast-2017-000145
13. Hibberd AA, Yde CC, Ziegler ML, Honoré AH, Saarinen MT, Lahtinen S, Stahl B, Jensen HM, Stenman LK. Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults. Benef Microbes, in press
14. Barrangou R, Briczinski EP, Traeger LL, Loquasto JR, Richards M, Horvath P, Coûté-Monvoisin A-C, Leyer G, Rendulic S, Steele JL. 2009. Comparison of the complete genome sequences of Bifidobacterium animalis subsp. lactis DSM 10140 and Bl-04. J Bacteriol 191:4144-4151. https://doi.org/ 10.1128/JB.00155-09
15. Briczinski EP, Loquasto JR, Barrangou R, Dudley EG, Roberts AM, Roberts RF. 2009. Strain-specific genotyping of Bifidobacterium animalis subsp. lactis by using single-nucleotide polymorphisms, insertions, and deletions. Appl Environ Microbiol 75:7501-7508. https://doi.org/10.1128/ AEM.01430-09
16. Loquasto JR, Barrangou R, Dudley EG, Stahl B, Chen C, Roberts RF. 2013. Bifidobacterium animalis subsp. lactis ATCC 27673 is a genomically unique strain within its conserved subspecies. Appl Environ Microbiol 79:6903-6910. https://doi.org/10.1128/AEM.01777-13
17. Milani C, Duranti S, Lugli GA, Bottacini F, Strati F, Arioli S, Foroni E, Turroni F, van Sinderen D, Ventura M. 2013. Comparative genomics of Bifidobacterium animalis subsp. lactis reveals a strict monophyletic bifidobacterial taxon. Appl Environ Microbiol 79:4304-4315. https://doi .org/10.1128/AEM.00984-13
18. Gueimonde M, Flórez AB, van Hoek AH, Stuer-Lauridsen B, Strøman P, Clara G, Margolles A. 2010. Genetic basis of tetracycline resistance in Bifidobacterium animalis subsp. lactis. Appl Environ Microbiol 76: 3364-3369. https://doi.org/10.1128/AEM.03096-09
19. Scott KP, Melville CM, Barbosa TM, Flint HJ. 2000. Occurrence of the new tetracycline resistance gene tet(W) in bacteria from the human gut. Antimicrob Agents Chemother 44:775-777. https://doi.org/10.1128/AAC .44.3.775-777.2000
20. Kazimierczak KA, Flint HJ, Scott KP. 2006. Comparative analysis of sequences flanking tet(W) resistance genes in multiple species of gut bacteria. Antimicrob Agents Chemother 50:2632-2639. https://doi.org/ 10.1128/AAC.01587-05
21. Raeisi SN, Ghoddusi HB, Boll EJ, Farahmand N, Stuer-Lauridsen B, Johansen E, Sutherland JP, Ouoba LII. 2018. Antimicrobial susceptibility of bifidobacteria from probiotic milk products and determination of the genetic basis of tetracycline resistance in Enterococcus species after in vitro conjugation with Bifidobacterium animalis subsp. lactis. Food Control 94:205-211. https://doi.org/10.1016/j.foodcont.2018.07.016
22. Aires J, Doucet-Populaire F, Butel M. 2007. Tetracycline resistance mediated by tet(W), tet(M), and tet(O) genes of Bifidobacterium isolates from humans. Appl Environ Microbiol 73:2751-2754. https://doi.org/10.1128/ AEM.02459-06
23. Flórez AB, Ammor MS, álvarez-Martín P, Margolles A, Mayo B. 2006. Molecular analysis of tet(W) gene-mediated tetracycline resistance in dominant intestinal Bifidobacterium species from healthy humans. Appl Environ Microbiol 72:7377-7379. https://doi.org/10.1128/AEM.00486-06
24. Chopra I, Roberts M. 2001. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65:232-260. https://doi.org/10.1128/MMBR .65.2.232-260.2001
25. Dodds DR. 2017. Antibiotic resistance: A current epilogue. Biochem Pharmacol 134:139-146. https://doi.org/10.1016/j.bcp.2016.12.005
26. Wilson DN. 2014. Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nat Rev Microbiol 12:35-48. https://doi.org/10 .1038/nrmicro3155
27. Nguyen F, Starosta AL, Arenz S, Sohmen D, Dönhöfer A, Wilson DN. 2014. Tetracycline antibiotics and resistance mechanisms. Biol Chem 395: 559-575. https://doi.org/10.1515/hsz-2013-0292
28. Roberts MC. 2005. Update on acquired tetracycline resistance genes. FEMS Microbiol Lett 245:195-203. https://doi.org/10.1016/j.femsle.2005 .02.034
29. The UniProt Consortium. 2017. UniProt: the universal protein knowledgebase. Nucleic Acids Res 45(D1):D158-D169. https://doi.org/10.1093/nar/ gkw1099
30. EFSA. 2012. Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EFSA J 10:2740
31. Fan F, Wood KV. 2007. Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol 5:127-136. https://doi.org/10.1089/ adt.2006.053
32. Hansen SJ, Morovic W, DeMeules M, Stahl B, Sindelar CW. 2018. Absolute enumeration of probiotic strains Lactobacillus acidophilus NCFM® and Bifidobacterium animalis subsp. lactis Bl-04® via chip-based digital PCR. Front Microbiol 9:704. https://doi.org/10.3389/fmicb.2018.00704
33. Loman NJ, Quick J, Simpson JT. 2015. A complete bacterial genome assembled de novo using only nanopore sequencing data. Nat Methods 12:733. https://doi.org/10.1038/nmeth.3444
34. O'Connell Motherway M, Watson D, Bottacini F, Clark TA, Roberts RJ, Korlach J, Garault P, Chervaux C, van Hylckama Vlieg JE, Smokvina T, van Sinderen D. 2014. Identification of restriction-modification systems of Bifidobacterium animalis subsp. lactis CNCM I-2494 by SMRT sequencing and associated methylome analysis. PLoS One 9:e94875. https://doi.org/ 10.1371/journal.pone.0094875
35. Arango-Argoty G, Garner E, Pruden A, Heath LS, Vikesland P, Zhang L. 2018. DeepARG: A deep learning approach for predicting antibiotic resistance genes from metagenomic data. Microbiome 6:23. https://doi .org/10.1186/s40168-018-0401-z
36. Ventola CL. 2015. The antibiotic resistance crisis: part 1: causes and threats. Pharm Ther 40:277-283
37. Scardovi V. 1965. The fructose-6-phosphate shunt as a peculiar pattern of hexose degradation in the genus Bifidobacterium. Ann Microbiol Enzymol 15:19-29
38. Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, Goossens H, Laxminarayan R. 2018. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A 115:E3463-E3470. https://doi.org/10.1073/pnas .1717295115
39. Lenski RE. 1998. Bacterial evolution and the cost of antibiotic resistance. Int Microbiol 1:265-270
40. Andersson DI, Levin BR. 1999. The biological cost of antibiotic resistance. Curr Opin Microbiol 2:489-493. https://doi.org/10.1016/S1369-5274(99)00005-3
41. Hwang TJ, Kim N, Kim HB, Lee BH, Nam RH, Park JH, Lee MK, Park YS, Lee DH, Jung HC. 2010. Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea. J Clin Gastroenterol 44:536-543. https://doi.org/10.1097/MCG.0b013e3181d04592
42. Sanders ME, Akkermans LM, Haller D, Hammerman C, Heimbach JT, Hörmannsperger G, Huys G. 2010. Safety assessment of probiotics for human use. Gut Microbes 1:164-185. https://doi.org/10.4161/gmic.1.3 .12127
43. ISO. 2010. ISO 10932:2010 (IDF 223:2010). Milk and milk products-determination of the minimal inhibitory concentration (MIC) of antibiotics applicable to bifidobacteria and non-enterococcal lactic acid bacteria (LAB). International Organization for Standards, Geneva, Switzerland
44. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P. 2007. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315:1709-1712. https://doi.org/ 10.1126/science.1138140
45. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816-821. https://doi.org/10.1126/science .1225829
46. Chan BK, Turner PE, Kim S, Mojibian HR, Elefteriades JA, Narayan D. 2018. Phage treatment of an aortic graft infected with Pseudomonas aeruginosa. Evol Med Public Health 2018:60-66. https://doi.org/10.1093/ emph/eoy005
47. Hidalgo-Cantabrana C, O'Flaherty S, Barrangou R. 2017. CRISPR-based engineering of next-generation lactic acid bacteria. Curr Opin Microbiol 37:79-87. https://doi.org/10.1016/j.mib.2017.05.015
48. Luo ML, Mullis AS, Leenay RT, Beisel CL. 2015. Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression. Nucleic Acids Res 43:674-681. https://doi.org/10.1093/nar/gku971
49. Paez-Espino D, Morovic W, Sun CL, Thomas BC, Ueda K-i, Stahl B, Barrangou R, Banfield JF. 2013. Strong bias in the bacterial CRISPR elements that confer immunity to phage. Nat Commun 4:1430. https:// doi.org/10.1038/ncomms2440
50. Briner AE, Lugli GA, Milani C, Duranti S, Turroni F, Gueimonde M, Margolles A, van Sinderen D, Ventura M, Barrangou R. 2015. Occurrence and diversity of CRISPR-Cas systems in the genus Bifidobacterium. PLoS One 10:e0133661. https://doi.org/10.1371/journal.pone.0133661
51. Hidalgo-Cantabrana C, Crawley AB, Sanchez B, Barrangou R. 2017. Characterization and exploitation of CRISPR loci in Bifidobacterium longum. Front Microbiol 8:1851. https://doi.org/10.3389/fmicb.2017.01851
52. Makarova KS, Wolf YI, Alkhnbashi OS, Costa F, Shah SA, Saunders SJ, Barrangou R, Brouns SJ, Charpentier E, Haft DH. 2015. An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol 13:722. https://doi.org/10.1038/nrmicro3569
53. Hidalgo-Cantabrana C, Sánchez B, Moine D, Berger B, Clara G, Gueimonde M, Margolles A, Ruas-Madiedo P. 2013. Insights into the ropy phenotype of the exopolysaccharide-producing strain Bifidobacterium animalis subsp. lactis A1dOxR. Appl Environ Microbiol 79:3870-3874. https://doi.org/10.1128/AEM.00633-13
54. Hidalgo-Cantabrana C, Sánchez B, Milani C, Ventura M, Margolles A, Ruas-Madiedo P. 2014. Genomic overview and biological functions of exopolysaccharide biosynthesis in Bifidobacterium spp. Appl Environ Microbiol 80:9-18. https://doi.org/10.1128/AEM.02977-13
55. Mistou M-Y, Sutcliffe IC, van Sorge NM. 2016. Bacterial glycobiology: rhamnose-containing cell wall polysaccharides in Gram-positive bacteria. FEMS Microbiol Rev 40:464-479. https://doi.org/10.1093/femsre/ fuw006
56. Heo A, Jang H-J, Sung J-S, Park W. 2014. Global transcriptome and physiological responses of Acinetobacter oleivorans DR1 exposed to distinct classes of antibiotics. PLoS One 9:e110215. https://doi.org/10 .1371/journal.pone.0110215
57. Yang M, Qin H, Wang W, Zhang H, Long Y, Ye J. 2018. Global proteomic responses of Escherichia coli and evolution of biomarkers under tetracycline stress at acid and alkaline conditions. Sci Total Environ 627: 1315-1326. https://doi.org/10.1016/j.scitotenv.2018.01.342
58. Darby AC, Gill AC, Armstrong SD, Hartley CS, Xia D, Wastling JM, Makepeace BL. 2014. Integrated transcriptomic and proteomic analysis of the global response of Wolbachia to doxycycline-induced stress. ISME J 8:925. https://doi.org/10.1038/ismej.2013.192
59. Caskey JR, Embers ME. 2015. Persister development by Borrelia burgdorferi populations in vitro. Antimicrob Agents Chemother 59:6288-6295. https://doi.org/10.1128/AAC.00883-15
60. Sibon OC, Strauss E. 2016. Coenzyme A: to make it or uptake it? Nat Rev Mol Cell Biol 17:605. https://doi.org/10.1038/nrm.2016.110
61. Jaehme M, Slotboom DJ. 2015. Diversity of membrane transport proteins for vitamins in bacteria and archaea. Biochim Biophys Acta 1850: 565-576. https://doi.org/10.1016/j.bbagen.2014.05.006
62. Rodionov DA, Hebbeln P, Eudes A, Ter Beek J, Rodionova IA, Erkens GB, Slotboom DJ, Gelfand MS, Osterman AL, Hanson AD. 2009. A novel class of modular transporters for vitamins in prokaryotes. J Bacteriol 191: 42-51. https://doi.org/10.1128/JB.01208-08
63. Goering AW, Li J, McClure RA, Thomson RJ, Jewett MC, Kelleher NL. 2017. In vitro reconstruction of nonribosomal peptide biosynthesis directly from DNA using cell-free protein synthesis. ACS Synth Biol 6:39-44. https://doi.org/10.1021/acssynbio.6b00160
64. Wang H, Fewer DP, Holm L, Rouhiainen L, Sivonen K. 2014. Atlas of nonribosomal peptide and polyketide biosynthetic pathways reveals common occurrence of nonmodular enzymes. Proc Natl Acad Sci U S A 111:9259-9264. https://doi.org/10.1073/pnas.1401734111
65. Ross JI, Eady EA, Cove JH, Cunliffe WJ. 1998. 16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrob Agents Chemother 42:1702-1705
66. Adam M, Murali B, Glenn NO, Potter SS. 2008. Epigenetic inheritance based evolution of antibiotic resistance in bacteria. BMC Evol Biol 8:52. https://doi.org/10.1186/1471-2148-8-52
67. Margolles A, Florez AB, Moreno JA, Van Sinderen D, Clara G. 2006. Two membrane proteins from Bifidobacterium breve UCC2003 constitute an ABC-type multidrug transporter. Microbiology 152:3497-3505. https:// doi.org/10.1099/mic.0.29097-0
68. Price CE, Reid SJ, Driessen AJ, Abratt VR. 2006. The Bifidobacterium longum NCIMB 702259T ctr gene codes for a novel cholate transporter. Appl Environ Microbiol 72:923-926. https://doi.org/10.1128/AEM.72.1 .923-926.2006
69. Wang S, Gao X, Gao Y, Li Y, Cao M, Xi Z, Zhao L, Feng Z. 2017. Tetracycline resistance genes identified from distinct soil environments in China by functional metagenomics. Front Microbiol 8:1406. https:// doi.org/10.3389/fmicb.2017.01406
70. Andrews S. 2010. FastQC: a quality control tool for high throughput sequence data. https://www.bioinformatics.babraham.ac.uk/projects/ fastqc/. Retrieved February 2018. (Software.)
71. Wick RR. 2018. PoreChop. https://github.com/rrwick/Porechop. Retrieved February 2018. (Software.)
72. Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114-2120. https://doi.org/10 .1093/bioinformatics/btu170
73. Wick RR, Judd LM, Gorrie CL, Holt KE. 2017. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 13:e1005595. https://doi.org/10.1371/journal.pcbi.1005595
74. Gurevich A, Saveliev V, Vyahhi N, Tesler G. 2013. QUAST: quality assessment tool for genome assemblies. Bioinformatics 29:1072-1075. https:// doi.org/10.1093/bioinformatics/btt086
75. Delcher AL, Salzberg SL, Phillippy AM. 2003. Using MUMmer to identify similar regions in large sequence sets. Curr Protoc Bioinformatics 1:10.3.1-10.3.18. https://doi.org/10.1002/0471250953.bi1003s00
76. Seemann T. 2014. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30:2068-2069. https://doi.org/10.1093/bioinformatics/btu153
77. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, Formsma K, Gerdes S, Glass EM, Kubal M. 2008. The RAST Server: rapid annotations using subsystems technology. BMC Genomics 9:75. https://doi.org/10 .1186/1471-2164-9-75
78. Overbeek R, Olson R, Pusch GD, Olsen GJ, Davis JJ, Disz T, Edwards RA, Gerdes S, Parrello B, Shukla M. 2014. The SEED and the rapid annotation of microbial genomes using subsystems technology (RAST). Nucleic Acids Res 42:D206-D214. https://doi.org/10.1093/nar/gkt1226
79. Wick RR, Schultz MB, Zobel J, Holt KE. 2015. Bandage: interactive visualization of de novo genome assemblies. Bioinformatics 31:3350-3352. https://doi.org/10.1093/bioinformatics/btv383
80. Darling AE, Mau B, Perna NT. 2010. progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One 5:e11147. https://doi.org/10.1371/journal.pone.0011147
81. Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, Rozen SG. 2012. Primer3-new capabilities and interfaces. Nucleic Acids Res 40:e115. https://doi.org/10.1093/nar/gks596
82. Liu B, Pop M. 2009. ARDB-antibiotic resistance genes database. Nucleic Acids Res 37:D443-D447. https://doi.org/10.1093/nar/gkn656
83. Jia B, Raphenya AR, Alcock B, Waglechner N, Guo P, Tsang KK, Lago BA, Dave BM, Pereira S, Sharma AN. 2017. CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res 45(D1):D566-D573. https://doi.org/10.1093/nar/ gkw1004
84. Reese MG. 2001. Application of a time-delay neural network to promoter annotation in the Drosophila melanogaster genome. Comput Chem 26:51-56. https://doi.org/10.1016/S0097-8485(01)00099-7
85. Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. https://doi.org/10.1186/s13059-014-0550-8